tm logo
SONFIDI
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 12 Oct 2018

Last Applicant/ Owned by

Gewerbestrasse 16

Allschwil

CH

4123

Serial Number

85326732 filed on 21st May 2011

Registration Number

4107974 registered on 06th Mar 2012

in the Principal Register

Correspondent Address

Lawrence E. Abelman

LAWRENCE E. ABELMAN

666 3RD AVE

NEW YORK, NY 10017-5621

Filing Basis

No Filing Basis

Disclaimer

NO DATA

SONFIDI

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, digital ulcers, glycolipid storage diseases, cerebrovascular diseases, diseases and disorders of the central nervous system and of the peripheral neurological system, neurodegenerative diseases and disorders, gastrointestinal disorders, anxiolytics, anti-all Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, digital ulcers, glycolipid storage diseases, cerebrovascular diseases, diseases and disorders of the central nervous system and of the peripheral neurological system, neurodegenerative diseases and disorders, gastrointestinal disorders, anxiolytics, anti-allergics, anti-infectives

Mark Details


Serial Number

No 85326732

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 875450

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Oct 2018CANCELLED SEC. 8 (6-YR)
06th Mar 2012REGISTERED-PRINCIPAL REGISTER
20th Dec 2011PUBLISHED FOR OPPOSITION
30th Nov 2011NOTICE OF PUBLICATION
17th Nov 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
09th Nov 2011APPROVED FOR PUB - PRINCIPAL REGISTER
27th Oct 2011TEAS/EMAIL CORRESPONDENCE ENTERED
27th Oct 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
26th Oct 2011ASSIGNED TO LIE
17th Oct 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED